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Vibrio cholerae has caused 7 global pandemics to date. The
7th ongoing pandemic caused by serogroup O1 El Tor has
been the most extensive in geographical spread and dura-
tion. It began in 1961 in Indonesia spreading through
Asia and the Middle East and finally reaching Sub Saharan
West Africa at the early 1970s, resulting in over 150,000
cases and more than 20,000 deaths during the first year.
V. cholerae is currently responsible for several outbreaks in
Africa, some with a reported high mortality rate. Although
extensive characterization has been carried out on epi-
demic strains in Asia, little information is available
regarding the characteristics of strains causing the recent
outbreaks in Africa. The aim of the present study is to
characterize at the genotypic level the different epidemio-
logic strains that are part of several outbreaks that
occurred in Africa during 2007. Different molecular tech-
niques are used in order to evaluate a reliable tool that can
be used to relate/discriminate the V. cholerae isolates
obtained from diverse geographical areas. This study will
investigate whether a cluster of isolates or a dominant
clone is responsible for the spread of the reported out-
breaks. Eighty isolates of V. cholerae were phenotypically
characterized using conventional microbiological proce-
dures such as biochemical testing and antimicrobial
resistance, and confirmed serologically by the slide agglu-
tination test using specific antiserum to V. cholera polyva-
lent O1 as well as serotype specific antisera for Inaba and
Ogawa subtypes. Molecular characterization of strains are
performed by using polymerase chain reaction (PCR),
multilocus variable tandem repeat analysis (MLVA),
mulitlocus sequence typing (MLST), and DNA sequencing
for several virulent genetic elements such as the cholera
toxin.
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